Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Koichiro, Matsumura"'
Autor:
Nobuhiro Yamada, Masafumi Ueno, Kyohei Onishi, Keishiro Sugimoto, Kazuyoshi Kakehi, Kosuke Fujita, Koichiro Matsumura, Gaku Nakazawa
Publikováno v:
Journal of Intensive Care, Vol 12, Iss 1, Pp 1-10 (2024)
Abstract Background The mortality rate of patients with cardiogenic shock (CS) requiring veno-arterial extracorporeal membrane oxygenation (VA-ECMO) combined with Impella (ECPELLA) support remains high. Inhaled nitric oxide (iNO) improves right ventr
Externí odkaz:
https://doaj.org/article/e3380fc52481491eac7b43db6605f1b8
Autor:
Koichiro Matsumura, Atsushi Nakagomi, Eijiro Yagi, Nobuhiro Yamada, Yohei Funauchi, Kazuyoshi Kakehi, Ayano Yoshida, Takayuki Kawamura, Masafumi Ueno, Gaku Nakazawa, Takahiro Tabuchi
Publikováno v:
JMIR Cardio, Vol 8, Pp e52266-e52266 (2024)
Abstract BackgroundTo prevent the further development of cardiovascular diseases, it is a growing global priority to detect untreated hypertension in patients and ensure adequate blood pressure control via drug therapy. However, few effective tools
Externí odkaz:
https://doaj.org/article/069c59e92a3d4f16a569eb0273c96ca5
Autor:
Ohki Hayashi, Seishi Nakamura, Tetsuro Sugiura, Shun Hasegawa, Yoshiaki Tsuka, Nobuyuki Takahashi, Sanae Kikuchi, Koichiro Matsumura, Toshika Okumiya, Masato Baden, Ichiro Shiojima
Publikováno v:
BMC Nephrology, Vol 24, Iss 1, Pp 1-9 (2023)
Abstract Background The improvement of anaemia over time by erythropoiesis stimulating agent (ESA) is associated with better survival in haemodialysis patients. We previously reported that erythrocyte creatine content, a marker of erythropoietic capa
Externí odkaz:
https://doaj.org/article/6feceb4db1534476b48b69f9c048d595
Autor:
Koichiro Matsumura MD, Takeshi Ijichi MD, Junko Morimoto MD, Kensuke Takabayashi MD, Mitsunori Miho MD, Keisuke Ueno MD, Eijiro Yagi MD, Toru Takase MD, Masafumi Ueno MD, Gaku Nakazawa MD
Publikováno v:
Journal of Cardiovascular Pharmacology and Therapeutics, Vol 28 (2023)
Aims: In recent large trials, sacubitril/valsartan demonstrated favorable effects in patients with HF. However, many patients do not achieve the target dose of treatment. This study investigated the factors linked to up-titration of sacubitril/valsar
Externí odkaz:
https://doaj.org/article/63ee933293324e94966036ad9926fade
Autor:
Shun Hasegawa, Seishi Nakamura, Tetsuro Sugiura, Yoshiaki Tsuka, Nobuyuki Takahashi, Koichiro Matsumura, Toshika Okumiya, Masato Baden, Ichiro Shiojima
Publikováno v:
BMC Nephrology, Vol 22, Iss 1, Pp 1-9 (2021)
Abstract Background One of the main causes of anaemia in patients with end-stage renal disease is relative deficiency in erythropoietin production. Eythropoiesis stimulating agent (ESA), a potent haematopoietic growth factor, is used to treat anaemia
Externí odkaz:
https://doaj.org/article/cc95294efc7b419c9aec6a270dde364a
Autor:
Koichiro Matsumura, Wakana Teranaka, Masanao Taniichi, Munemitsu Otagaki, Hiroki Takahashi, Kenichi Fujii, Yoshihiro Yamamoto, Gaku Nakazawa, Ichiro Shiojima
Publikováno v:
ESC Heart Failure, Vol 8, Iss 3, Pp 1819-1826 (2021)
Abstract Aims We aimed to investigate the differences in the prevalence, severity, and prognostic impact of malnutrition between patients with new‐onset heart failure (HF) and worsening of chronic HF. Methods and results In older (≥60 years) hosp
Externí odkaz:
https://doaj.org/article/6590e2f9084e4d22a57e36e7328169b6
Autor:
Koichiro Matsumura, Wakana Teranaka, Hiroshi Matsumoto, Kenichi Fujii, Satoshi Tsujimoto, Munemitsu Otagaki, Shun Morishita, Kenta Hashimoto, Hiroki Shibutani, Yoshihiro Yamamoto, Ichiro Shiojima
Publikováno v:
ESC Heart Failure, Vol 7, Iss 6, Pp 4100-4107 (2020)
Abstract Aims Loss of skeletal muscle mass is an important determinant associated with poor long‐term prognosis in patients with acute decompensated heart failure (ADHF). However, limited evidence is available. This study investigated the prognosti
Externí odkaz:
https://doaj.org/article/961e3bb3aaa44d08a5d0c4dcca6ffff9
Autor:
Koichiro Matsumura, Toshika Okumiya, Tetsuro Sugiura, Nobuyuki Takahashi, Yoshihiro Yamamoto, Sanae Kikuchi, Kenichi Fujii, Munemitsu Otagaki, Ichiro Shiojima
Publikováno v:
BMC Nephrology, Vol 21, Iss 1, Pp 1-7 (2020)
Abstract Background The causes of anaemia in patients with end-stage renal disease include a relative deficiency in erythropoietin production and complex clinical conditions. We aimed to investigate the underlying mechanisms of anaemia in patients wi
Externí odkaz:
https://doaj.org/article/85100b00e73d4be48acef866ef83f9d6
Autor:
Hiromi Kin, Koichiro Matsumura, Yoshihiro Yamamoto, Kenichi Fujii, Munemitsu Otagaki, Hiroki Takahashi, Haengnam Park, Kei Yoshioka, Mitsuru Yokoi, Tetsuro Sugiura, Ichiro Shiojima
Publikováno v:
ESC Heart Failure, Vol 7, Iss 4, Pp 1764-1770 (2020)
Aims Although tolvaptan has been reported to prevent worsening renal function (WRF) in patients with advanced acute heart failure (AHF), evidence regarding the effect of tolvaptan on renal function in patients with new‐onset AHF is not available. T
Externí odkaz:
https://doaj.org/article/41b80ede6628429ba33ee693a78a614a
Autor:
Koichiro Matsumura, Tetsuro Sugiura
Publikováno v:
Cardiovascular Ultrasound, Vol 17, Iss 1, Pp 1-6 (2019)
Abstract A high incidence of left ventricular diastolic dysfunction and increased risk of cardiovascular events have been reported in patients with diabetes mellitus. Sodium glucose cotransporter 2 (SGLT2) inhibitors selectively inhibit kidney glucos
Externí odkaz:
https://doaj.org/article/5a88fa4494124825a7bd5d86e4a45b11